Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

BACKGROUND: Demonstrating therapeutic value from the patient perspective is important in patient-centered migraine management. The objective of this study was to investigate the impact of eptinezumab, a preventive migraine treatment, on patient-reported headache impact, acute medication optimization...

Descripción completa

Detalles Bibliográficos
Autores principales: McAllister, Peter, Winner, Paul K., Ailani, Jessica, Buse, Dawn C., Lipton, Richard B., Chakhava, George, Josiassen, Mette Krog, Lindsten, Annika, Mehta, Lahar, Ettrup, Anders, Cady, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903522/
https://www.ncbi.nlm.nih.gov/pubmed/35130832
http://dx.doi.org/10.1186/s10194-021-01376-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903522/
https://www.ncbi.nlm.nih.gov/pubmed/35130832
http://dx.doi.org/10.1186/s10194-021-01376-7

Ejemplares similares